Inducement Grants
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Re: Inducement Grants
Over the past two months 1,745,210 share options of GERN have been granted to newly hired employees. There must be some serious heavy hitters sitting in the dugout right now...........
https://ir.geron.com/investors/press-re ... fault.aspx
https://ir.geron.com/investors/press-re ... fault.aspx
......stay tuned!! -Kmall
https://ir.geron.com/investors/press-re ... fault.aspx
https://ir.geron.com/investors/press-re ... fault.aspx
......stay tuned!! -Kmall
Re: Inducement Grants
Sarfraz Haroon - Associate Director, Clinical Data Management at Geron Corporation
Hired - October 2022
10/20/2022 - FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) reported that it has granted non-statutory stock options to purchase an aggregate of 843,260 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Sarfraz Haroon is one of these newly hired employees.
Sarfraz Haroon's former employers include: Bristol Meyers Squibb, Shionogi Inc., Novartis, INC Research
Geron's last four announced hires have been in the Clinical Operations Dept. It looks like Geron is firing on all cylinders with 3 ongoing Clinical Trials and the IMpress CT ready to initiate at any moment. One must wonder if Clinical Trial Designs for Lymphoid Malignancies are currently on the back burner..........we shall soon see. -Kmall
Hired - October 2022
10/20/2022 - FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) reported that it has granted non-statutory stock options to purchase an aggregate of 843,260 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Sarfraz Haroon is one of these newly hired employees.
Sarfraz Haroon's former employers include: Bristol Meyers Squibb, Shionogi Inc., Novartis, INC Research
Geron's last four announced hires have been in the Clinical Operations Dept. It looks like Geron is firing on all cylinders with 3 ongoing Clinical Trials and the IMpress CT ready to initiate at any moment. One must wonder if Clinical Trial Designs for Lymphoid Malignancies are currently on the back burner..........we shall soon see. -Kmall